Modification of ultrasonographically measured endometrial thickness after discontinuation of adjuvant therapy with tamoxifen in postmenopausal breast cancer patients

European Journal of Gynaecological Oncology

Volumn 25, Issue 3, 2004, Pages 321-323

  Menada, M Valenzano ^a,c   Papadia, A ^a   Lorenzi, P ^a   Costantini, S ^a   Bertelli, G F ^b   Ragni, N ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

Endometrial thickness; Tamoxifen; Ultrasonography

Indexed keywords

TAMOXIFEN;

ANALYSIS OF VARIANCE; ARTICLE; BREAST CANCER; DRUG WITHDRAWAL; ENDOMETRIUM; ENDOMETRIUM CANCER; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; POLYP; POSTMENOPAUSE; SIDE EFFECT; STATISTICAL ANALYSIS; TRANSVAGINAL ECHOGRAPHY; TREATMENT OUTCOME;

BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; ENDOMETRIUM; FEMALE; HUMANS; MIDDLE AGED; POSTMENOPAUSE; SELECTIVE ESTROGEN RECEPTOR MODULATORS; TAMOXIFEN;

EID: 2342642161     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Jordan V.C.: "Tamoxifen: the herald of a new era of preventive therapeutics [editorial]". J. Natl. Cancer Inst., 1997, 89, 747.
2. Early Breast Cancer Trialists' Collaborative Group: "Tamoxifen for early breast cancer: an overview of the randomised trials". Lancet, 1998, 351, 1451.
3. ACOG Committee Opinion: "Tamoxifen and endometrial cancer". Int. J. Gyn. Obst., 2001, 73, 77.
4. Osborne C.K.: "Tamoxifen in the treatment of breast cancer". N. Engl. J. Med., 1998, 339, 1609.
5. Fisher B., Dignam J., Wolmark N. et al.: "Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B- 24 randomised controlled trial". Lancet, 1999, 353, 1993.
6. Fisher B., Costantino J.P., Wickerham D.L. et al.: "Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study". J. Natl. Cancer Inst., 1998, 90, 1371.
7. Mourits M.J.E., De Vries E.G.E., Willense P.H.B. et al.: "Tamoxifen treatment and gynecologic side effects: A review". Obstet. Gynecol., 2001, 97 (5 part 2), 855.
8. Marchesoni D., Driul L., Fabiani G. et al.: "Endometrial histologic changes in post-menopausal breast cancer patients using Tamoxifen". Int. J. Gynecol. Obstet., 2001, 75 (3), 257.
9. Mourits M.J.E., Van der Zee A.G.J., Willanse P.H.B. et al.: "Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using Tamoxifen". Gynecol. Oncol., 1999, 73, 21.
10. Bernstein L., Deapen D., Cerhan J.R. et al.: "Tamoxifen therapy for breast cancer and endometrial cancer risk". J. Natl. Cancer Inst., 1999, 91 (19), 1654.
11. Bergman L., Beelen M.L.R., Gallee M.P.W. et al.: "Risk and prognosis of endometrial cancer after Tamoxifen for breast cancer". Lancet, 2000, 356, 881.
12. Pukkala E., Kyyronen P., Sankila R. et al.: "Tamoxifen and Toremifene treatment of breast cancer and risk of subsequent endometrial cancer: a population - based case control study". Int. J. Cancer, 2002, 100 (3), 337.
13. Kedar R.P., Bourne T.H., Powels T.J. et al.: "Effects of Tamoxifen on uterus and ovaries of post-menopausal women in a randomised breast cancer prevention trial". Lancet, 1994, 343, 1318.
14. Cohen I., Rosen D.J.D., Shapira J. et al.: "Endometrial changes with Tamoxifen: comparison between Tamoxifen treated and non-treated asymptomatic, post-menopausal breast cancer patients". Gynecol. Oncol., 1994, 52, 185.
15. Cohen I., Azaria R., Shapira J. et al.: "Significance of secondary ultrasonographic endometrial thickening in postmenopausal Tamoxifen treated women". Cancer, 2002, 94 (12), 3101.
16. Cohen I., Beyth Y., Tepper R.: "The role of ultrasound in the detection of endometrial pathologies in asymptomatic postmenopausal breast cancer patients with Tamoxifen treatment". Obstet. Gynecol. Surv., 1998, 53 (7), 429.
17. Gerber B., Krause A., Müller H. et al.: "Effects of adjuvant Tamoxifen on the endometrium in postmenopausal women with breast cancer: a prospective long-term study using transvaginal ultrasound". J. Clin. Oncol. 2000, 18 (20), 3464.
18. Juneja M., Jose R., Kekre A.N. et al.: "Tamoxifen induced endometrial changes in postmenopausal women with breast carcinoma". Int. J. Gynecol. Obstet., 2002, 76 (3), 279.
19. Seoud M., Shamseddle A., Khalil A. et al.: "Tamoxifen and endometrial pathologies: a prospective study". Gynecol. Oncol., 1999, 75, 15.
20. Barakat R.R., Gilewski T.A., Almadrones L. et al.: "Effect of adjuvant Tamoxifen on the endometrium in women with breast cancer: a prospective study using office endometrial biopsy". J. Clin. Oncol., 2000, 18 (20), 3459.
21. Love C.D.B., Muir B.B., Scrimgeour J.B. et al.: "Investigation of endometrial abnormalities in asymptomatic women treated with Tamoxifen and an evaluation of the role of endometrial screening". J. Clin. Oncol., 1999, 17 (7), 2050.
22. Tabor A., Watt H.C., Wald N.J.: "Endometrial thickness as a test for endometrial cancer in women with postmenopausal vaginal bleeding". Obstet. Gynecol., 2002, 99 (4), 663.
23. Cohen I., Beyth Y., Azzaria R. et al.: "Ultrasonographic measurement of endometrial changes following discontinuation of Tamoxifen treatment in postmenopausal breast cancer patients". Br. J. Obstet. Gynecol., 2000, 107, 1083.
24. Gonçalves M.A.G., Gonçalves W.J., Matias M.M. et al.: "Hysteroscopic evaluation of the endometrium of post-menopausal patients with breast cancer before and after Tamoxifen use". Int. J. Gynecol. Obstet., 1999, 66 (3), 273.
25. Liedman R., Lindahl B., Andolf E. et al.: "Disaccordance between estimation of endometrial thickness as measured by transvaginal ultrasound compared with hysteroscopy and directed biopsy in breast cancer patients treated with Tamoxifen". Anticancer Res., 2000, 20, 4889.